Delivery Order SPE2DB20D3101-SPE2DB22FQUV3

Award Date 9/14/22
Potential Completion Date 9/15/22
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,420.51 firm fixed-price delivery order is for the supply of 4,564,544 units of doxycycline monohydrate 100 mg capsules. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,111.99 firm fixed-price delivery order is for the supply of 4,567,571,531 units of Doxycycline Mono 100 mg capsules in 50-count packages. The award has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,358.93, is for the delivery of 4,566,846,892 units of Doxycycline Hyclate 100 mg tablets with an ultimate completion date of January 7, 2025. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,728.28 firm fixed-price delivery order is for the supply of 4,567,482,567 Doxycycline Mono 100 mg tablets in 250-count bottles. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $75,624.41, is for the delivery of 4,543,086,193 doxycycline 100mg tablets in packages of 500. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,619,033 units of Doxycycline Hyclate 100 mg capsules. The fixed-price delivery order, valued at $1,350.96, has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $1,256.28, was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,564,673,556 units of Doxycycline Hyclate 50 mg capsules, with a completion date of May 22, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,164.84 and is a delivery order for 4,567,649,603 units of Doxycycline Hyclate 100 mg tablets. The contract has an ultimate completion date of March 24, 2025 and is a firm fixed-price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,384.51 firm fixed-price delivery order is for the supply of 4565821772 units of Doxycycline Mono 100 mg capsules. The contract has a completion date of September 17, 2024 and is not designated as a set-aside. Amerisourcebergen has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by defense and...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,567,622,735 units of doxycycline 100mg tablets, with a ceiling value of $5,993.00. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB22FQUV3
    Delivery Order

This federal contract award, valued at $1,905.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,558,461,377 units of Doxycycline Mono 100 mg capsules, a generic antibiotic medication. The contract is a Firm Fixed Price Delivery Order with a completion date of September 15, 2022.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:24 AM